Literature DB >> 14132657

ATAXIA-TELANGIECTASIA. ITS ASSOCIATION WITH A DEFECTIVE THYMUS, IMMUNOLOGICAL-DEFICIENCY DISEASE, AND MALIGNANCY.

R D PETERSON, W D KELLY, R A GOOD.   

Abstract

Entities:  

Keywords:  ABNORMALITIES; ANTIBODIES; ATAXIA; BONE MARROW EXAMINATION; CHILD; GAMMA GLOBULIN; GENETICS, HUMAN; IMMUNITY; LYMPH NODES; LYMPHOSARCOMA; NEOPLASM IMMUNOLOGY; PLASMA CELLS; PNEUMOMEDIASTINUM, DIAGNOSTIC; RETICULOENDOTHELIOSIS; TELANGIECTASIS; THYMUS GLAND; TRANSPLANTATION IMMUNOLOGY

Mesh：

Substances：

Year:  1964        PMID： 14132657     DOI： 10.1016/s0140-6736(64)91209-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  60 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  The Immunological System of the Child: Part II: Immunological Deficiency States.

Authors:  C A Janeway
Journal:  Arch Dis Child       Date:  1966-08       Impact factor: 3.791

3.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

4.  Autoimmunity in the relatives of patients with immunodeficiency diseases.

Authors:  J M Friedman; P J Fialkow; S D Davis; H D Ochs; R J Wedgwood
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

5.  "Experiments of Nature" and the New Era of Immunology: an historical perspective.

Authors:  Raymond D A Peterson
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  The wasted mutant mouse. II. Immunological abnormalities in a mouse described as a model of ataxia-telangiectasia.

Authors:  D Kaiserlian; W Savino; J Uriel; J Hassid; M Dardenne; J F Bach
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

7.  Abnormalities in the distribution of serum immunoglobulin concentrations in juvenile rheumatoid arthritis.

Authors:  J T Cassidy; R E Petty; D B Sullivan
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

8.  Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia.

Authors:  T A Waldmann; S Broder; C K Goldman; K Frost; S J Korsmeyer; M A Medici
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

9.  ATAXIA-TELANGIECTASIA.

Authors:  H G DUNN; H MEUWISSEN; C S LIVINGSTONE; K K PUMP
Journal:  Can Med Assoc J       Date:  1964-11-21       Impact factor: 8.262

Review 10.  Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature.

Authors:  C Sirinavin; A A Trowbridge
Journal:  J Med Genet       Date:  1975-12       Impact factor: 6.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.